Correlation Between Brpr Corporate and Neurocrine Biosciences
Can any of the company-specific risk be diversified away by investing in both Brpr Corporate and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Brpr Corporate and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Brpr Corporate Offices and Neurocrine Biosciences, you can compare the effects of market volatilities on Brpr Corporate and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Brpr Corporate with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Brpr Corporate and Neurocrine Biosciences.
Diversification Opportunities for Brpr Corporate and Neurocrine Biosciences
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Brpr and Neurocrine is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Brpr Corporate Offices and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Brpr Corporate is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Brpr Corporate Offices are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Brpr Corporate i.e., Brpr Corporate and Neurocrine Biosciences go up and down completely randomly.
Pair Corralation between Brpr Corporate and Neurocrine Biosciences
Assuming the 90 days trading horizon Brpr Corporate Offices is expected to generate 0.44 times more return on investment than Neurocrine Biosciences. However, Brpr Corporate Offices is 2.27 times less risky than Neurocrine Biosciences. It trades about 0.11 of its potential returns per unit of risk. Neurocrine Biosciences is currently generating about -0.15 per unit of risk. If you would invest 4,487 in Brpr Corporate Offices on November 28, 2024 and sell it today you would earn a total of 244.00 from holding Brpr Corporate Offices or generate 5.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
Brpr Corporate Offices vs. Neurocrine Biosciences
Performance |
| Timeline |
| Brpr Corporate Offices |
| Neurocrine Biosciences |
Brpr Corporate and Neurocrine Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Brpr Corporate and Neurocrine Biosciences
The main advantage of trading using opposite Brpr Corporate and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Brpr Corporate position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.| Brpr Corporate vs. Fresenius Medical Care | Brpr Corporate vs. MAHLE Metal Leve | Brpr Corporate vs. Medical Properties Trust, | Brpr Corporate vs. Delta Air Lines |
| Neurocrine Biosciences vs. Elevance Health, | Neurocrine Biosciences vs. Brpr Corporate Offices | Neurocrine Biosciences vs. ON Semiconductor | Neurocrine Biosciences vs. STMicroelectronics NV |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |